VIROPHARMA INC company info

CIK 946840
IRS Number 232789550
State of incorporation DE
Business address 730 STOCKTON DRIVE
Mail address 730 STOCKTON DRIVE

Short summary

VIROPHARMA INC is a Pennsylvania company, with head office located at 730 Stockton Drive Exton, Pennsylvania 19341. In 2013 the company owned a total of 1.14 billion USD worth of assets, including 494.63 million USD worth of current assets. 2011 was the year when the company amassed the most assets.

VIROPHARMA INC Income Statement

Name [in Millions USD]200820092010201120122013Trends
Selling, General and Administrative Expense 89.3295.66127.78174.32
Research and development 52.0839.6166.4867.71
Operating Income (Loss) 32.13211.70222.1333.34
Interest expense 11.6111.6212.6414.09
Other Nonoperating Income (Expense) 0.43-2.14-0.82
Income Tax Expense (Benefit) 41.0375.2867.3513.41
Net income -11.08125.61140.66


Name [in Millions USD]200820092010201120122013Trends
Cash and cash equivalents 275.84352.46390.40357.21191.40205.59
Accounts Receivable, Net, Current 68.6854.6155.9561.48
Inventories 61.2841.0987.83100.12
Deferred income taxes 11.2910.0612.96
Property, Plant and Equipment, Gross 18.3821.2225.6528.25
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 6.919.2313.3614.19
Goodwill 6.4599.3096.2696.80
Intangible Assets, Net (Excluding Goodwill) 611.48630.21494.39489.58
Other Assets, Noncurrent 11.2017.4619.7420.60
Total assets 1,328.781,401.291,113.111,136.20
Current assets 676.17621.70468.53494.63
Accounts payable 13.526.5016.4116.13
Taxes Payable, Current 0.804.540.410.10
Total current liabilities 90.88196.8889.7691.79
Long-term Debt 149.52157.54159.63
Deferred income taxes 173.57174.35120.05115.90
Total liabilities 416.16544.40403.33408.29
Common Stock, Value, Issued
Retained Earnings (Accumulated Deficit) 233.10330.31256.73260.92
Accumulated Other Comprehensive Income (Loss), Net of Tax 0.910.74-3.05-3.80-3.10


Name [in Millions USD]200820092010201120122013Trends
Net income -11.08125.61140.66
Depreciation 1.802.402.90
Amortization of Intangible Assets 28.1829.3631.0435.30
Depreciation and amortization 29.6631.2133.4737.82
Deferred Income Tax Expense (Benefit) 28.1619.90-19.44-19.85
Accounts receivable 262.1034.86-4.21
Inventories 13.6212.326.943.25
Accounts payable -1.494.01-0.169.30
Net Cash Provided by (Used in) Operating Activities 84.78193.52170.73
Payments to Acquire Property, Plant, and Equipment 1.932.813.011.33
Payments to Acquire Businesses, Net of Cash Acquired 32.04
Net Cash Provided by (Used in) Investing Activities -8.93-101.93-101.05
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -101.93-101.05-38.05
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 11.8311.1714.24
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures 11.8311.1714.24
Proceeds from Issuance of Common Stock 0.383.5414.6911.96
Payments for Repurchase of Common Stock 169.66180.34
Net Cash Provided by (Used in) Financing Activities -20.453.57-163.21
Cash and Cash Equivalents, Period Increase (Decrease) 55.8395.06-95.38